India's Glenmark pioneering through prioritising preclinical
Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority.
Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority.
Gene expression analysis expert Exiqon is to pay up to $45m (€30.7m) for diagnostics company Oncotech as a first step towards becoming a world leading miRNA diagnostic manufacturer.
Covance has announced the $35m sale of its electrocardiogram (ECG) unit in order to focus on its core businesses.
Denmark-based CMC Biopharmaceuticals has snapped up Eli Lilly's recently acquired biologics facility for an undisclosed amount.
Bruker BioSciences is to acquire the affiliated, but privately-held Bruker BioSpin group for $914m (€620m) in a bid to expand its distribution capabilities and increase its customer base.
Medgenics' Biopump could be the solution to the issues surrounding protein therapy and is set to take on the $51bn US biopharmaceutical market after raising £3.28m ($6.76m) in funding in its Initial Public Offering.